4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-19-016381
Chief Commercial Officer sold 10,000 shares at an average $67.01 ($670,050)
- Chief Commercial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hoerter Steven L. Chief Commercial Officer | 2019-03-01 | Option exercise | +5,000 | $39.76 | $198,800 | 15,941 | D |
| Hoerter Steven L. Chief Commercial Officer | 2019-03-01 | Sale | −5,000 | $66.01 | $330,050 | 10,941 | D |
| Hoerter Steven L. Chief Commercial Officer | 2019-03-04 | Option exercise | +5,000 | $39.76 | $198,800 | 15,941 | D |
| Hoerter Steven L. Chief Commercial Officer | 2019-03-04 | Sale | −5,000 | $68.00 | $340,000 | 10,941 | D |
| Derivatives | |||||||
| Hoerter Steven L. Chief Commercial Officer | 2019-03-01 | Option exercise · Stock option (right to buy) | −5,000 | 55,650 | D | ||
| Hoerter Steven L. Chief Commercial Officer | 2019-03-04 | Option exercise · Stock option (right to buy) | −5,000 | 50,650 | D | ||
| Open-market sales · 10,000 sh · avg $67.01 · $670,050 | |||||||
Loading xslF345X03/doc4.xml…